Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA:688336)
China · Delayed Price · Currency is CNY 86.04
+0.57 (0.67%)
Apr 14, 2026, 3:00 PM CST
SHA:688336 Market Cap
SHA:688336 has a market cap or net worth of 53.18 billion as of April 14, 2026. Its market cap has increased by 215.14% in one year.
Market Cap
53.18B
Enterprise Value
51.42B
Revenue
4.20B
Ranking
n/a
PE Ratio
18.08
Stock Price
86.04
Market Cap Chart
Since July 22, 2020, SHA:688336's market cap has increased from 33.34B to 53.18B, an increase of 59.52%. That is a compound annual growth rate of 8.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 52.83B | 43.78% |
| Dec 31, 2025 | 36.74B | 178.10% |
| Dec 31, 2024 | 13.21B | -4.84% |
| Dec 29, 2023 | 13.88B | 77.24% |
| Dec 30, 2022 | 7.83B | -31.47% |
| Dec 31, 2021 | 11.43B | -24.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Haisco Pharmaceutical Group | 62.25B |
| Pharmaron Beijing | 52.44B |
| Beijing Wantai Biological Pharmacy Enterprise | 49.41B |
| Shanghai Allist Pharmaceuticals | 43.52B |
| Asymchem Laboratories (Tianjin) | 42.60B |
| Hebei Changshan Biochemical Pharmaceutical | 37.74B |
| Chongqing Zhifei Biological Products | 37.65B |
| Shanghai RAAS Blood Products | 37.64B |